Professionals and executives specializing in Rx-to-OTC switch, regulatory affairs, brand marketing, and medical affairs are all invited to attend DGE’s 3rd Rx-to-OTC Switch being held in Philadelphia February 26-27, 2024. This summit aims to educate switch teams to design strategies to guarantee a successful switch, analyze new regulations surrounding ACNU, discuss the impact of e-commerce on OTC products, and navigate potential marketing challenges between health care professionals and consumers.
This conference is hosted by Dynamic Global Events, a leading event company that organizes B2B conferences for healthcare organizations. This platform is a viable forum for education, discussion, and interaction among peers and many industry professionals. Global leaders and industry experts from…
For more information, please visit https://ibn.fm/JZXeu.
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]
InvestorWire is powered by IBN